Compd. IC50(μM)
B16 A549 Bel-7402 K562
Taxolb 0.96 ± 0.01 0.72 ± 0.04 0.45 ± 0.10 0.91 ± 0.02
2 29.87± 3.64 33.08 ± 0.15 39.67± 4.22 42.03± 1.21
3 20.62± 1.02 29.70 ± 0.34 33.78± 2.12 38.33± 1.31
14
15a
19.39± 0.18
7.98 ± 0.29
20.92± 1.60
9.34 ± 0.54
21.85± 0.73
11.97 ± 0.06
22.69± 0.09
12.23 ± 0.12
15b 10.75 ± 0.14 10.09 ± 0.20 14.87 ± 0.24 15.56 ± 0.52
15c 11.92 ± 0.09 11.27 ± 0.33 15.01 ± 0.09 16.14 ± 0.43
15d 9.65 ± 0.31 9.60 ± 0.14 11.95 ± 0.19 12.48 ± 0.31
15e 9.71 ± 0.20 10.62 ± 0.11 14.70 ± 0.20 16.22 ± 0.14
15f 10.01 ± 0.13 10.33 ± 0.07 15.85 ± 0.12 16.01 ± 0.30
15g 11.89 ± 0.08 12.91 ± 0.05 15.54 ± 0.09 17.96 ± 0.11
15h 16.74 ± 0.12 17.74 ± 0.09 18.01 ± 0.04 19.41 ± 0.26
15i 20.81 ± 0.14 21.87 ± 0.28 22.70 ± 0.15 25.05 ± 0.14
20a 6.40 ± 0.42 8.05 ± 0.12 9.02 ± 0.16 8.46 ± 0.05
20b 6.93 ± 0.06 9.71 ± 0.30 10.17 ± 0.01 10.08 ± 0.06
20c 6.98 ± 0.04 10.03 ± 0.05 13.06 ± 0.03 12.10 ± 0.07
20d 6.29 ± 0.22 8.78 ± 0.19 9.08 ± 0.42 9.34 ± 0.15
20e 7.13 ± 0.16 9.85 ± 0.11 10.21 ± 0.08 11.72 ± 0.12
20f 7.97 ± 0.14 9.92 ± 0.16 13.13 ± 0.15 13.98 ± 0.08
20g 11.15 ± 0.31 10.94 ± 0.14 14.98 ± 0.13 15.81 ± 0.10
20h 15.16 ± 0.18 16.72 ± 0.17 17.81 ± 0.10 16.56 ± 0.09
20i 19.27 ± 0.15 20.60 ± 0.16 21.02 ± 0.11 23.14 ± 0.08
aResults are expressed as IC50 values in μM. b Taxol was used as a positive control.
Table 1: IC50 values of the target compounds against four human tumor cell linesa.